Production (Stage)
Terns Pharmaceuticals, Inc.
TERN
$3.02
$0.082.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 334.26M | 358.16M | 372.78M | 225.30M | 240.65M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.48M | 3.95M | 3.73M | 4.94M | 5.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 337.75M | 362.11M | 376.51M | 230.24M | 245.90M |
|
|
|||||
| Total Current Assets | 337.75M | 362.11M | 376.51M | 230.24M | 245.90M |
| Net Property, Plant & Equipment | 1.22M | 1.47M | 1.67M | 587.00K | 816.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 351.00K | 350.00K | 56.00K | 55.00K | 55.00K |
| Total Assets | 339.32M | 363.93M | 378.23M | 230.88M | 246.77M |
|
|
|||||
| Total Accounts Payable | 2.78M | 2.15M | 1.79M | 1.87M | 1.70M |
| Total Accrued Expenses | 7.15M | 12.62M | 8.88M | 8.51M | 6.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 429.00K | 428.00K | 272.00K | 249.00K | 427.00K |
| Total Finance Division Other Current Liabilities | 580.00K | 455.00K | 477.00K | 320.00K | 532.00K |
| Total Other Current Liabilities | 580.00K | 455.00K | 477.00K | 320.00K | 532.00K |
| Total Current Liabilities | 10.94M | 15.65M | 11.41M | 10.96M | 8.83M |
|
|
|||||
| Total Current Liabilities | 10.94M | 15.65M | 11.41M | 10.96M | 8.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 806.00K | 919.00K | 1.03M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.53M | 1.49M | 1.32M | 1.24M | 1.22M |
| Total Liabilities | 13.27M | 18.06M | 13.76M | 12.20M | 10.05M |
|
|
|||||
| Common Stock & APIC | 771.38M | 767.63M | 763.99M | 596.86M | 592.04M |
| Retained Earnings | -445.39M | -421.48M | -399.68M | -377.74M | -355.00M |
| Treasury Stock & Other | 51.00K | -279.00K | 160.00K | -443.00K | -321.00K |
| Total Common Equity | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M |
|
|
|||||